Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GREM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
RBMS3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IL36G - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ACOT12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ADAMTS6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OFCC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101928574 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
LGALS13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WDFY3-AS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TARP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SSX3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LMBRD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GUCA1C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SYN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TIGD4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on